Table 4 The differences of parameters between HCBS negative patients with MSA-C and SCA with a disease duration within 1 year.
Total (N = 61) | SCA (N = 46) | MSA-C (N = 15) | P value | ||
|---|---|---|---|---|---|
Disease duration | 0.90 ± 0.30 | 0.89 ± 0.31 | 0.93 ± 0.26 | 0.638 | |
Cerebellum | NAA/Cr | 0.89 ± 0.16 | 0.94 ± 0.13 | 0.74 ± 0.13 | 0.000 |
Cho/Cr | 0.72 ± 0.16 | 0.75 ± 0.16 | 0.64 ± 0.12 | 0.000 | |
Vermis | NAA/Cr | 0.84 ± 0.09 | 0.86 ± 0.08 | 0.77 ± 0.08 | 0.001 |
Cho/Cr | 0.67 ± 0.09 | 0.69 ± 0.09 | 0.62 ± 0.06 | 0.003 |
Total (N = 51) | SCA (N = 39) | MSA-C (N = 12) | P value | ||
|---|---|---|---|---|---|
SARA score | 7.15 ± 4.49 | 6.40 ± 4.22 | 9.58 ± 4.64 | 0.039 |